Top Page
China BlueChemical
(OTC:3983)
China BlueChemical (3983) vs. iShares MSCI Hong Kong ETF (EWH)
China BlueChemical Business Overview & Revenue Model
China BlueChemical Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.95B | 12.99B | 14.28B | 13.40B | 10.42B |
| Gross Profit | 1.70B | 2.06B | 2.54B | 2.94B | 1.33B |
| EBITDA | 1.55B | 3.33B | 2.35B | 2.76B | 1.32B |
| Net Income | 1.07B | 2.38B | 1.64B | 1.50B | 745.49M |
Balance Sheet | |||||
| Total Assets | 24.08B | 24.32B | 23.50B | 21.43B | 20.75B |
| Cash, Cash Equivalents and Short-Term Investments | 13.51B | 13.74B | 13.03B | 11.46B | 10.17B |
| Total Debt | 2.12B | 2.02B | 2.08B | 1.05B | 1.98B |
| Total Liabilities | 4.57B | 4.91B | 5.72B | 4.52B | 5.12B |
| Stockholders Equity | 18.41B | 18.30B | 16.75B | 15.83B | 14.70B |
Cash Flow | |||||
| Free Cash Flow | 918.02M | 800.48M | 806.70M | 1.88B | 890.36M |
| Operating Cash Flow | 1.52B | 1.54B | 2.14B | 2.94B | 1.26B |
| Investing Cash Flow | -379.00M | -691.13M | -2.35B | -3.66B | 1.11B |
| Financing Cash Flow | -1.06B | -784.06M | 65.37M | -1.37B | -415.86M |
China BlueChemical Technical Analysis
China BlueChemical Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$9.13B | 7.94 | 10.52% | 4.36% | -4.50% | 58.32% | |
79 Outperform | HK$7.11B | 4.26 | 17.58% | 4.82% | -3.45% | 20.63% | |
73 Outperform | HK$9.59B | 8.25 | 5.83% | 6.33% | -9.71% | -56.34% | |
58 Neutral | HK$17.12B | 4.56 | -6.43% | 5.15% | -3.18% | -62.89% | |
51 Neutral | HK$1.92B | 96.74 | 0.59% | ― | -21.05% | -87.68% | |
42 Neutral | €13.25B | ― | -16.73% | ― | -29.52% | -73.10% | |
39 Underperform | HK$853.76M | ― | -81.86% | ― | -4.88% | -34.75% |
China BlueChemical Corporate Events
China BlueChemical Ltd. has announced an extraordinary general meeting (EGM) scheduled for August 18, 2025, to discuss significant changes in its corporate governance structure. The meeting will focus on amending the company’s articles of association and the cancellation of its supervisory committee, which may impact the company’s operational framework and governance.
China BlueChemical has entered into a series of structured deposit agreements with the Bank of China (BOC) Hainan Branch, totaling RMB850 million. These transactions, which involve self-owned funds, are classified as discloseable under Hong Kong Listing Rules due to their aggregated transaction amounts exceeding 5% of applicable percentage ratios. This strategic financial maneuver is expected to enhance the company’s liquidity management while adhering to regulatory requirements.
China BlueChemical, a joint stock limited company incorporated in China, has entered into two structured deposit agreements with ICBC Hainan Branch, subscribing to products worth RMB400 million and RMB300 million respectively. These transactions, which involve self-owned funds, are classified as discloseable under Hong Kong Listing Rules due to the aggregated transaction amounts exceeding certain percentage thresholds, necessitating notification and announcement but not shareholder approval.
China BlueChemical Ltd. held its 2024 Annual General Meeting (AGM) along with class meetings for H Shareholders and Domestic Shareholders, where key resolutions were approved, including the distribution of final dividends and the appointment of new directors. The AGM saw a significant turnout with 74.73% of shares represented, highlighting strong shareholder engagement. The approval of budget proposals and re-appointment of auditors indicates a stable financial strategy moving forward, while the appointment of new directors suggests a strategic shift in leadership to enhance the company’s governance and operational efficiency.
China BlueChemical Ltd. has announced the composition of its Board of Directors, highlighting the roles and functions of each member. The board consists of executive, non-executive, and independent non-executive directors, with four committees established to oversee various aspects of the company’s governance. This announcement underscores the company’s commitment to structured governance and transparency, potentially impacting stakeholder confidence and operational oversight.
China BlueChemical Ltd. has announced a final cash dividend of RMB 0.1208 per share for the financial year ending December 31, 2024, with the payment to be made in Hong Kong dollars at a rate of HKD 0.1316 per share. This announcement reflects the company’s stable financial performance and commitment to delivering shareholder value, while also detailing the withholding tax implications for non-resident enterprise shareholders.
China BlueChemical Ltd. has announced proposed amendments to its Articles of Association, aiming to enhance corporate governance and streamline operations. The key change involves the cancellation of the supervisory committee, with its functions being transferred to the audit committee of the Board. This move aligns with recent regulatory updates and reflects the company’s commitment to improving its governance structure, potentially impacting its operational efficiency and stakeholder relations.
China BlueChemical, through its subsidiary CNOOC Jiantao, has entered into agreements with the Bank of China Hainan Branch to subscribe to structured deposit products totaling RMB450 million. These transactions, classified as discloseable under Hong Kong Listing Rules, do not require shareholder approval but necessitate notification and announcement due to the aggregated transaction amounts exceeding 5% of applicable percentage ratios.
China BlueChemical Ltd. has announced a final cash dividend of RMB 0.1208 per share for the financial year ending December 31, 2024. The announcement includes key dates for shareholders, such as the ex-dividend date on June 2, 2025, and the payment date on June 30, 2025. The company will withhold a 10% enterprise income tax for dividends distributed to non-resident enterprises. This announcement reflects the company’s commitment to returning value to its shareholders and may impact its financial positioning and attractiveness to investors.
China BlueChemical Ltd. has announced its upcoming annual general meeting scheduled for May 29, 2025, where several key resolutions will be considered. These include the approval of the board and supervisory committee reports, audited financial statements, profit distribution, and budget proposals for 2025. Additionally, the re-appointment of auditors and the appointment of new directors will be discussed. A special resolution will also be considered to grant the board a mandate to issue domestic and overseas shares, subject to regulatory approvals. This meeting is significant for stakeholders as it outlines the company’s strategic direction and governance for the upcoming year.
China BlueChemical Ltd. has announced a special resolution to be considered at its upcoming H Shareholders’ Class Meeting, which involves granting the board of directors a mandate to repurchase up to 10% of its overseas listed foreign shares, known as H Shares. This move is aimed at optimizing the company’s capital structure and potentially enhancing shareholder value, reflecting a strategic focus on market conditions and operational needs.
China BlueChemical Ltd. has announced a Domestic Shareholders’ Class Meeting to discuss and potentially approve a special resolution granting the board of directors the authority to repurchase up to 10% of its overseas listed foreign shares (H Shares). This move is aimed at aligning with market conditions and the company’s needs, potentially impacting its capital structure and shareholder value. The resolution will empower the board to manage the repurchase details, including pricing and timing, and make necessary amendments to the company’s articles of association to reflect any changes in registered capital.
China BlueChemical Ltd. has announced the closure of its register of members for H shares in preparation for its 2024 annual general meeting and class meetings scheduled for May 29, 2025. This move is aimed at determining the list of H shareholders eligible to attend and vote at these meetings, which are significant for the company’s governance and stakeholder engagement.